Skip to content

Schering-Plough SGP EPS (Diluted)

EPS (Diluted) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.14-52.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$6.75-7.2%
Glaukos logo
GlaukosGKOS
-$0.34-6.3%
AbbVie logo
AbbVieABBV
$0.39-45.8%
Bausch + Lomb logo
Bausch + LombBLCO
-$0.20+66.7%
HRO
HarrowHROW
-$0.74-48.0%

Other financials

Income statement

See full
Operating income-$15.4M-108%
Net income-$13.8M-56.6%

Balance sheet

See full
Cash & equivalents$238.9M+312%
Total debt$1.6M
Total equity$250.1M+463%
Total assets$258.4M

Cash flow

See full
Operating cash flow-$13.5M-65.2%
CapEx$676.0K+312%
Free cash flow-$14.2M-70.0%

Valuation

See full
Market cap$744.23M-23.4%
Enterprise value$506.93M

Returns & leverage

See full
Return on equity-34.3%
Debt / equity
Current ratio38×

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Schering-Plough’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schering-Plough's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schering-Plough's EPS (diluted)?
Schering-Plough (SGP) reported EPS (diluted) of -$0.69 in Q1 2026.
How has Schering-Plough's EPS (diluted) changed year-over-year?
Schering-Plough's EPS (diluted) increased by 82.6% year-over-year, from -$3.96 to -$0.69.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.